OC
SANA icon

Oppenheimer & Co’s Sana Biotechnology SANA Stock Holding History

Oppenheimer & Co’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,200
Closed -$158K – 1570
2021
Q4 		$158K Sell
10,200
-17,950
-64% -$346K ﹤0.01% 1419
2021
Q3 		$634K Sell
28,150
-900
-3% -$18.9K 0.01% 920
2021
Q2 		$571K Sell
29,050
-100
-0.3% -$2.27K 0.01% 963
2021
Q1 		$976K Buy
+29,150
New +$949K 0.02% 714

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Oppenheimer & Co's SANA Position: Q1 2022 in Review

Oppenheimer & Co sold out of Sana Biotechnology (SANA) in Q1 2022, closing a stake of 10,200 shares — an estimated $158K sold.

Oppenheimer & Co first reported a position in SANA in Q1 2021 and held it in 4 quarters. The position peaked at $976K in Q1 2021. 117 funds tracked by Wall St. Rank hold SANA as of Q1 2022.

  • Oppenheimer & Co reported no remaining Sana Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 10,200 Sana Biotechnology shares in Q1 2022, an estimated $158K.
  • Oppenheimer & Co first reported a position in Sana Biotechnology in Q1 2021 and held it in 4 quarters.
  • Oppenheimer & Co's Sana Biotechnology position peaked at $976K in Q1 2021.
  • 117 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2022.

Based on Oppenheimer & Co's 13F filing for Q1 2022, filed 12 May 2022.